Bio

Robert Coyne practices corporate transactional law, primarily in the area of mergers and acquisitions and strategic alliances. He focuses on middle-market deals for clients ranging from closely-held businesses to large international groups. Through such transactional work, Mr. Coyne has developed extensive knowledge of intellectual property protection, executive employment arrangements, corporate structures, supply chain contracts, cross-border M&A issues, and complex indemnities. Whether on the sell-side or the buy-side, he understands the key business value drivers and helps his clients realize their goal of a quick and successful sale or strategic alliance. Many of Mr. Coyne’s clients are in the life sciences industry, including pharmaceutical, biotech, medical device, diagnostic, and medical communications companies. He understands the financing and development challenges faced by the owners and management of these companies. He has also steered clients through the intricacies of financings, including early-stage, growth, and mezzanine fundings. Having represented many clients through development to commercialization, Mr. Coyne has deep experience with agreements covering research, clinical trials, collaboration, manufacturing, distribution, and licensing. By working closely with clients to fully understand their business issues, Mr. Coyne gains the clarity and insight to help them successfully address difficult legal challenges that can arise in the course of their signings, closings, and other corporate transactions.